Air pollution is at its worse at present and millions of people suffer from various respiratory diseases due to this. One of the most common ailments related to breathing is asthma. Its prevalence has increased dramatically in the last few years which in turn has proven to be beneficial for the global asthma inhaler devices market forecast.
Asthma Inhaler Device Market is expected to register a CAGR of 6.42% during the forecast period with a market value of USD 19,677.54 Million. Inhaler devices have been proved to be the safest and most effective way to treat and control asthma and other respiratory diseases, as the inhaled medication reaches the lungs directly.
Currently, the children and old people are the most susceptible to this disease. If young kids get this disease, they might end up losing their productivity and to avoid this parent use respiratory inhaler devices market to keep their little one’s condition stable. This fact works like a charm for this market and helps it to expand its reach.
MRFR recognizes the following as the key players in the Global asthma inhaler device market companies— GlaxoSmithKline plc (UK), Koninklijke Philips NV (Netherlands), AstraZeneca (UK), Cipla Inc. (India), Boehringer Ingelheim International GmbH (Germany), Beximco Pharmaceuticals Ltd (Bangladesh), Merck & Co., Inc. (US), Teva Pharmaceutical Industries Ltd (Israel), Chiesi Farmaceutici SpA (Italy), and Medisol Lifescience Pvt. Ltd (India).
The Global Asthma Inhaler Device Market has been segmented by Type, Mode of Operation, and End User.
- By mode of device type, the global inhaler devices market has been segmented into dry-powder inhaler, metered-dose inhaler, MDI with a spacer, and others.
- By mode of technology, the global inhaler devices market has been segmented into digitally operated and manually operated inhaler devices.
- By mode of end-users, the global inhaler devices market has been segmented into research institutes, clinics, hospitals, and others.
The Global Asthma Inhaler Device Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas are likely to hold the largest share of the global asthma inhaler device market during the assessment period. The increase in the incidence of asthma, rising demand for metered-dose inhalers, adoption of smart inhalers by the population, and increasing demand for advanced technologies is expected to drive the market growth in the American region.
The Europe market established substantial growth in the market due to the presence of major players such as GlaxoSmithKline PLC, AstraZeneca, and Boehringer Ingelheim, the rising adoption of respiratory inhalers by hospitals and patients in European countries and continuous efforts made by the European Academy of Allergy & Clinical Immunology to increase awareness about asthma.
Asia-Pacific is estimated to be the fastest-growing region in the global market due to the presence of rapidly developing economies such as China, India, and South Korea and the high prevalence of asthma.
The asthma inhaler device market in the Middle East & Africa is expected to witness gradual growth owing to increasing cases of asthma and demand for better treatments in the Middle Eastern countries.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312